{"name":"DreaMed Diabetes","slug":"dreamed-diabetes","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Multiple Daily Injections of Insulin","genericName":"Multiple Daily Injections of Insulin","slug":"multiple-daily-injections-of-insulin","indication":"Type 1 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"Multiple Daily Injections of Insulin","genericName":"Multiple Daily Injections of Insulin","slug":"multiple-daily-injections-of-insulin","phase":"marketed","mechanism":"Multiple daily insulin injections replace or supplement the body's own insulin production to regulate blood glucose levels.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus (when oral agents are insufficient)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBrMnY0NTJyWXdNLUNCWTN6alFObjA3SWZqZHBYVGdVNTdhdUpGVDh2cDZ3OEpZTjgxQUhCTU1YZ2F3ODZ4NVJOcWhXRWFXbmRESnlPV1JpazdGTFhIMzU1dkt2YzRPZ2dDa1dDaQ?oc=5","date":"2026-02-05","type":"pipeline","source":"Common Dreams","summary":"TrumpRx Denounced as Corrupt Scheme to Line Pockets of Big Pharma—and Don Jr. - Common Dreams","headline":"TrumpRx Denounced as Corrupt Scheme to Line Pockets of Big Pharma—and Don Jr.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOZU5TdjdvQUR6eFBVUlF3dG1pa2oxWHRxQk5SZzlIZWpMZDlJVTNXT1Z6YjRYRllRRXk5U1Q2SnltaUtBeW9mU0FWNy1QSHBqb0VGZ1N0S2tOUnFHZ21WcVNwdkU0dHprbWJQUnpwbTZpTEVvQ0xDVFRrbWI4bGhkTXczcW5BTXNqRVEtc01SSGdtM1RHNDNpSkI5a2ZyQmpHUE5tR2pB?oc=5","date":"2025-12-16","type":"pipeline","source":"HealthCentral","summary":"This Top Cyclist Is Chasing His Dreams With Type 1 Diabetes - HealthCentral","headline":"This Top Cyclist Is Chasing His Dreams With Type 1 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPODVQNEM5ZHNSQjM5Z2Nrb0xXcVc1OXZrbFgwTlRUSC15X1VsUnRDaUYybDl0VEpJRFBjTVNrLVU3d2x0MXdOQjh6WDFsNDNPbUJiVjd3V3ZyQi0tWTJDTTZQX0NRVWh2bXV1VkpaX0dPSFF1eHdiU29FQ3J4T2ctYWtMRzN5SjA0TFFTY1UxZmVxNU0zV3BLSk9YMFFPcFd3VzlVbG1jMWJ4Mzly?oc=5","date":"2025-10-30","type":"pipeline","source":"mediapost.com","summary":"Pharma Giant Sanofi Chases 'The Miracles Of Science' In Corporate Campaign 10/30/2025 - mediapost.com","headline":"Pharma Giant Sanofi Chases 'The Miracles Of Science' In Corporate Campaign 10/30/2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9rTmRVd3ZCb05IUVhmRkFkclNDU3FzUGM2ZTR3V2djV1JUbEttLUN2ajNMSXFTRUp1WGpNWElBRV9MUmJRV3loVnVWVVJkY1FObG1r?oc=5","date":"2025-10-27","type":"trial","source":"FirstWord Pharma","summary":"Innovent's Lilly-partnered mazdutide tops Novo's Ozempic in late-stage study - FirstWord Pharma","headline":"Innovent's Lilly-partnered mazdutide tops Novo's Ozempic in late-stage study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPQ0d0VmdieHp1ajFIZ2tEVm1fUVBRaU04Q0YxNU1UNnBCVDNCWUFxaEI1NjYwbEhxeWNkT1NsSzY3bm5XQU9WYUZicElsUjdmWE1fZXhINC0xVWtRYkt5Q0g3WVRTU3V5UGl1Q1lLeXpOVUNLUDBUZV96N0t6ekthN0Q2Nl9mdUNSU1VTMDNRN2haQVJXN0NCcER2V2MzaDYtX29OR2V6RFNidTlvaEdkMGRpS19PZHVuelNWVF9Sd0ZQOXM0aTN4ckF2bDVhNkRFTV95eEEzN1VSMXg3M2kxVA?oc=5","date":"2025-10-26","type":"regulatory","source":"Reuters","summary":"China's Innovent says its GLP-1 works better than Novo's semaglutide in diabetes study - Reuters","headline":"China's Innovent says its GLP-1 works better than Novo's semaglutide in diabetes study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQNzhlQnkxWWJ0XzA3MlRrV2R0bVFGNUw2b1dfdXl3QThnRTJvSlRvWUxyZ2hXdDVYM05DMjdsLWhDM3UtaHo5cE9CVlVpMEJlbDJmWGl4dWpyZDhWNmNDbEwzcFVRRWhJS2NDejJvYmdzNWF1akFFSnplRlEzdVVYNGphQmZvWXFCZ1NmUEJsQ1dyeVExNXNMaGRfcUVtcFZ3Z2dIaU40ZFozWUlaTEljSmRXbU9RSjdoWGxkQWw1ZGVKOWpFX2V1dV9LQzgzeHVtN3NBY1F0MjZCWFBtVHdtM1FZdWRpYmh6NnViaXlhM0h5dnB4M2o1RUltZ1ZPS3M?oc=5","date":"2025-06-24","type":"trial","source":"BioSpace","summary":"Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented at ADA 85th Scientific Sessions - BioSpace","headline":"Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented at ADA 85th Scientifi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeTltMTlDTkZJQ19BQWliejVEQ0s5S3U0UzRIVE5UNEUxYmo1WHZCWXlPZk1qVUcwR25HY0EtRVlJd2UtcG1IaVlhdHNzdXJoZUFPRjVPaDVhUEZQd0ZjaGpCZnVMemRMWW03S0lyenZCYVhMY2FyZGFxaDR2ZTVGd1U5eGdCSnpTOGVreThNcEp5SEU2emJob2RMUFlKQTBGeDRUSVp3b1JqTXVvdDU3VkdoNkw5aVd4VngyRDUydw?oc=5","date":"2024-03-12","type":"regulatory","source":"Fierce Pharma","summary":"5 years after initial FDA rejection, Lexicon prepares to resubmit Type 1 diabetes hopeful Zynquista - Fierce Pharma","headline":"5 years after initial FDA rejection, Lexicon prepares to resubmit Type 1 diabetes hopeful Zynquista","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPa05mOG5UdWlhc0RSWkpMYlBPYWFlOWdkTHNjZUh3djJhSUQ5QTV0VExEcjVQVlRqN0ZRTzlZOXVpYUJpZkZTRHh3dXVaOGIxR0lfT3ZfNkVyaVpSbmJ0dk9sRW9NYVlUdEV6blNmZ3Vud1drVGdSUnRJdUFzN1c1ZlZ2eHpLZDFheHkwU3pza3RWdmVVbnNScWIzOG5vN0l3S3c?oc=5","date":"2023-05-25","type":"pipeline","source":"healthtransformer.co","summary":"Introducing the Type 1 Diabetes Moonshot Fellowship Community - healthtransformer.co","headline":"Introducing the Type 1 Diabetes Moonshot Fellowship Community","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNamFITG9vSnE5eUszTDQ2b2dWenphUGtoTjY2WHpjbi0yVWxmalVsSWtxWHpkNXU3emdQMk5FVlFYeDVXLWwweHh0ZVpCVENwcFNlQ0FIWTFsekpKYW5oMlRDS1ExRnBzVnNPNG9peWZra3ViRHdyYTlwVGRPa3lfWVk2QnJCV0g5WW1makYtMzZOOUN4Uzh4dVVnWWtRMWRhSVB3ZTBoZXNnaHJLQWtUQVpqX3U?oc=5","date":"2022-04-26","type":"pipeline","source":"Breakthrough T1D","summary":"ATTD Conference Brings Together Top Minds in Diabetes Research - Breakthrough T1D","headline":"ATTD Conference Brings Together Top Minds in Diabetes Research - Breakthrough T1D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQN1BxZW1oMVdLQ0x5b1Z3cXdTV1VyZTVick5fOW1NemJsV3N2c21jUGQ4elNteEVWMnVBTkRmNWttU1VMTmowT3pCdWR4QnVSVFI0akJLX3oxVzZ2eHRVLTV0U01HS2lGeVE2aFdqM3RUSUtfUXVKSG5Eb0NodHpmNVhNUHBWSjdiYmlyZm1idHcxX1JZejZHWXN4di1JeDFEY3RSSGxWWjM5dTlZMFRpOTlKdmlJSzVZUjNtZlZNMU9DZw?oc=5","date":"2021-10-08","type":"regulatory","source":"Fierce Biotech","summary":"DreaMed Diabetes' 'digital endocrinologist' AI expands to Type 2 diabetes with FDA green light - Fierce Biotech","headline":"DreaMed Diabetes' 'digital endocrinologist' AI expands to Type 2 diabetes with FDA green light","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPX3htTzhUSnZjcVhJVDIwN1RzeGVkV2hNcTNfaFA0UXpNMkc2eGJBSk1fajktYXlKU1dCOTJld2w3YTd6dlltSU1mUlBIWnpQc20yNG1XTDRENUZRWFVub2hrbTBHOUR1ZTFfME1pV3piUGxWaXd4eTFEX0FtcVV1RTJ3Nk15d3NpZ292UGtjZnptNk1FcXYwQXIxUHp1VmlYcUtFbndmT2l4M3E4TllJSTR2a3dyTDg?oc=5","date":"2021-10-07","type":"regulatory","source":"MobiHealthNews","summary":"FDA greenlights DreaMed's AI-backed insulin management tool for folks with Type 2 diabetes - MobiHealthNews","headline":"FDA greenlights DreaMed's AI-backed insulin management tool for folks with Type 2 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQOG1QQXNXcWg2bnZ3OUxucHlrS0FoUk9LUm9pVXlOVWF0RDlfNVBpOFpqYmhMcmRydkg2QzBNV2dZWWlmQUtaM0VjelNyaVNYYWg3V2g0UTVjcWp4QkQxUVVnS0tRUjJZdlkwSU1iRW1talVlQU9vSVM4SWx3Mko5b3h4QjlvYmQ4amVjY2dNSm9sVTZKNVRpNkd4aWFBa3lUM05BUmliVlNmaTRyS0NtYTBnaG41OGIyTlFMX1o1c3d2M19hd1RGWWxJblFaeVd4NzZsQVJvaDRMSUc4Mmc3aTRabS1JVDZk?oc=5","date":"2021-10-06","type":"regulatory","source":"Business Wire","summary":"DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System - Business Wire","headline":"DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}